Caricamento...
Survival Advantage of Trans-Arterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy
PURPOSE: To measure TACE utilization and survival benefit among patients with HCC in the SEER patient population. METHOD AND METHODS: A retrospective study identified 37, 832 patients with HCC diagnosed between 1991 and 2011. Survival was estimated by Kaplan-Meier method and compared using the log r...
Salvato in:
| Pubblicato in: | J Vasc Interv Radiol |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5258671/ https://ncbi.nlm.nih.gov/pubmed/27939085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvir.2016.09.022 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|